Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-028370
Filing Date
2019-05-08
Accepted
2019-05-08 20:14:00
Documents
2
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9194
2 POA DOCUMENT poa.txt EX-24.3_851461 3587
  Complete submission text file 0001209191-19-028370.txt   14190
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CHELSEA THERAPEUTICS, INC. 3530 TORINGDON WAY, SUITE 200 CHARLOTTE NC 28277
Business Address
Oliveto Joseph (Reporting) CIK: 0001437782 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38899 | Film No.: 19808428